- Time: 10:30am - 11:30am
- Track: Clinical Practice
- CME/CE: 1.0
- Type: In-Person, Virtual
Moderator: Sunny Linnebur, PharmD, FCCP, BCPS, FASCP, BCGP
Presenters: Daniel E. Forman, MD & Ariel R. Greene, MD, MPH, PhD
This session will present key findings related to the assessment of Arteriosclerotic Cardiovascular Disease (ASCVD) risk in adults over age 75 years and the evidence for LDL-C lowering in this population. Learning Objectives: (1) discuss limitations of evidence and recommendations related to older adults based on life expectancy, functional status, and cognitive status; (2) review evidence for adverse effects of statin therapies in this population; and (4) describe evidence for deprescribing.